医学
美罗华
观察研究
地塞米松
免疫性血小板减少症
内科学
肿瘤科
儿科
淋巴瘤
血小板
作者
Ying Liang,Cong Tang,Chunyu Liu,Lu Zhang,Yi Fang,Anqi Zhao,Nannan Chen
标识
DOI:10.1080/17474086.2024.2420633
摘要
The combination of dexamethasone, rituximab, and cyclosporine may present a promising therapeutic option for patients with refractory ITP, with good tolerability and mild adverse reactions.
科研通智能强力驱动
Strongly Powered by AbleSci AI